A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services

NCT02517554 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2024-01-19

No results posted yet for this study

Summary

The goal of this research is to evaluate the relative advantage of remote counseling over usual care in community health practices without access to genetic services. We will evaluate ability of remote telemedicine, referred to going forward as TeleGenetic services (phone or videoconferencing), to increase uptake of genetic testing and identification of genetic carriers compared to usual care. Secondly, we will evaluate the advantages of videoconferencing over telephone for delivery of remote genetic services and the short-term and longitudinal outcomes of TeleGenetic services in socio-demographically diverse patients in community practices.

Conditions

Interventions

BEHAVIORAL

Penn genetic counselors provides counseling and test results disclosure by videoconferene to patient at community site

Baseline and follow up survey

BEHAVIORAL

Penn genetic counselor provides counseling and test results disclosure by telephone to patient at community site

Baseline and follow up surveys

BEHAVIORAL

Patient receives written information on how to find genetic services in their area

Baseline and follow up surveys

Sponsors & Collaborators

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Principal Investigators

  • Angela Bradbury, MD · Abramson Cancer Center at Penn Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2018-03-31
Completion
2019-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02517554 on ClinicalTrials.gov